GNBTQ Generex Biotechnology Corp.

Why the Chatter at Laguna Conference Matters Alright folks, here's the scoop that the suits over at Lear are gearing up for: a fireside chat at the Morgan Stanley 14th Annual Laguna Conference. At first glance, you might shrug and say, "Big deal." But what's a conference worth if not to attract a bit of investor buzz, right? With Ray Scott, the President and CEO, and...

Breaking Down Bexicaserin's Dual Action Seems like Lundbeck's playing the long game with bexicaserin, and boy, are they shaking things up at the European Epilepsy Congress. This isn't your usual sit-back-and-watch situation. They're putting bexicaserin's dual mode of action under a magnifying glass, aiming to hit both sides of the brain's seesaw by increasing inhibitory...

Qapture Investments just made a move in the digital finance space that's promising to turn some heads. From acquiring Flammarion Partners to snapping up Hermetik Trading's DeFi strategies, this Bermuda-based investment manager isn't here to play. Led by Frederick Pye, the firm's gearing up for an industry takeover by blending regulation with innovative digital finance...

Shihezi's Global Stage: A Week of Shared Opportunities Shihezi, tucked away in the far reaches of Xinjiang, China, has become a hub of global discourse this week. Here's the kicker—an International Week filled with events aiming to connect the dots between technological innovation and agricultural advancement kicked off on August 31. Look, they've got experts and...

Regenerative Medicine: A New Frontier in Spine Care When spine care gets a facelift, you take notice. Joseph Spine Institute, a heavyweight in the spine care game, just threw hat into the regenerative ring. We're talking about using a patient's own cells to mend what's broken—that's advanced. They're launching a Regenerative Therapy Center in Tampa, ready to offer these...

Shifting Gears: Gan & Lee's Major European Play Picture it—Asian biopharma juggernaut Gan & Lee Pharmaceuticals is hitching a ride with Europe's Menarini Group to take its flagship, bofanglutide, across the vast European market. It's a move that's got shades of grand ambition, colorful strategy, and not a small sum riding on its success. Cracking the Metabolic Code The...

Insurance Innovation Hits Missouri Here's something you don't see every day: an insurance company pushing tech boundaries, and it goes by the name Lemonade. This company, trading under NYSE:LMND, is throwing something fresh at Missouri—car insurance that's not just another spoonful of the same old. They've paired Lemonade Car with Lemonade Autonomous Car, offering a...

Is Hyperscale Making the Right Move? Hyperscale Data, Inc. waved goodbye to the Bitcoin mining days to clear the stage for artificial intelligence (AI). But is this strategic leap off the blockchain and into AI territory as golden as promised? Whisper around the street is it could turn into a $3 billion windfall. But let's chew through the details before toasting...

Greenberg Traurig Welcomes David M. Herzog to the Team Ah, the rat race of litigation just got a bit fiercer with Greenberg Traurig's latest acquisition: David M. Herzog. This isn’t just another lawyer joining the ranks; Herzog's a dynamo, coming in hot from the U.S. Attorney's Office, right onto the battlefield of corporate litigation. Why Herzog's Move Matters...

MD Integrations Paves a New Path in Telehealth Well, folks, it seems someone’s finally listening. MD Integrations is taking a serious swing at solving one of telehealth's big hiccups – compliance delays. By roping in LegitScript directly, they’re all set to smooth the rocky road to launching virtual care brands. The Sticky Issue of Compliance Delays Anyone dabbling...

Thryv Announces New Sales Leadership Team Thryv (NASDAQ: THRY), recognized as a leading software platform catering to small businesses, has taken a significant step forward with two pivotal appointments within its sales leadership. The company has promoted Fran Lee to serve as the Vice President of North American Sales. In his elevated position, Lee will navigate the...

Danske Bank's Share Buy-Back Initiative: A Closer Look Danske Bank A/S has recently undertaken a significant move by launching a share buy-back program totaling DKK 5.5 billion, which aims to repurchase up to 70 million shares. This program, announced in early February, is set to unfold over the course of nearly a year, demonstrating the bank's commitment to returning...

Investor Alert: Ongoing Investigation of DexCom As investment opportunities continue to evolve, it's vital to protect your rights as an investor. If you've lost more than $100,000 in DexCom, you’re encouraged to connect with Faruqi & Faruqi, LLP, a reputable national securities law firm known for its dedication to advocating for shareholders. Legal Options for Investors...

Impressive Growth of Vanguard Information Tech ETF Vanguard Information Tech ETF (NYSE: VGT) has shown remarkable performance over the past decade, consistently outpacing the overall market by a substantial margin of 8.6% on an annualized basis. With an impressive average annual return of 21.27%, this ETF has garnered attention from both seasoned investors and newcomers...

Bluestone Resources Secures Final Court Approval for Acquisition Bluestone Resources Inc. (the "Company" or "Bluestone") proudly announces that it has received a final order from the Supreme Court allowing the much-anticipated acquisition by Aura Minerals Inc. The arrangement showcases a significant shift in the direction of the Company, promising exciting developments...